Hospital AI Lab Practical information on medical AI for UAE hospitals

Updated:

Medical technology and research in the United Arab Emirates

What is the United Arab Emirates publishing and testing in medicine right now? This page collects papers whose author affiliations include the United Arab Emirates and drug trials with sites there, all from the last 12 months, in three groups: surgical techniques, new drugs and therapies, and diseases.

Period: 2025-11-16 to 2026-11-16 · updated automatically every week

How to read this page
  • This is an automatic list of titles, journals, dates and links from PubMed and ClinicalTrials.gov. We do not copy abstracts or article text, and we have not checked the findings.
  • A paper or a trial existing is not evidence that a treatment works or is safe, and it is not medical advice. Ask your clinician about any treatment.
  • “Papers from the United Arab Emirates” means at least one author affiliation mentions the country; it does not mean the whole study was done there.
  • Titles are shown in their original language (mostly English).

Surgical techniques

Minimally invasive, robot-assisted, endoscopic, joint replacement and transplant papers.

Showing the latest 12 of 186 matches

  1. Predicting Motor Recovery in the Subacute Phase of Stroke: The Role of Passive Motor Task and Electroencephalogram Brain Networks

    Brain Connect 2026-11-13 Kim DH, Kwon GH, Park W et al. PMID 43023807

  2. Total Hip Arthroplasty versus Hemiarthroplasty for Displaced Fragility Femoral Neck Fractures in Older Adults: A Systematic Review and Meta-Analysis of Mortality, Reoperation, and Surgical Complications

    J Arthroplasty 2026-11-09 Pierce TP, Badawi JM, Alhammadi H et al. PMID 43003361

  3. Extensor Pollicis Longus Rupture After Distal Radius Fracture: Incidence, Associations, and Functional Outcomes in a Prospective Cohort

    J Hand Surg Glob Online 2026-11-06 Sayed-Noor AS, Abo Jouma HA, Al-Amiry B et al. PMID 43034826

  4. Subtype-Specific Treatment of Autoimmune Myocarditis: Current Evidence and Clinical Approach

    Cardiol Rev 2026-11-03 Goh ZY, Ahmad R, Chadalavada B et al. PMID 42972640

  5. Game-Based Learning and Gamification in Laparoscopic Skills Education: Meta-Analysis and Systematic Review

    JMIR Serious Games 2026-10-29 Meng X, Wan Z, Li W et al. PMID 42956019

  6. Repair versus replacement of defective composite restorations: Teaching in dental schools in Canada

    J Dent 2026-10-17 Daood U, Malik NA, Sidhu P et al. PMID 42892357

  7. Six-month comparative outcomes of endoscopic sleeve gastroplasty versus laparoscopic sleeve gastrectomy: an MBSAQIP analysis

    Surg Endosc 2026-10-15 Mocanu V, Wills MV, Zhu X et al. PMID 42881311

  8. Insights on Novel Dental Resin Composites: A Scoping Review

    Polymers (Basel) 2026-10-14 Ping LK, Al-Rawas M, Abuhijleh E et al. PMID 42942637

  9. Ultrasound-guided percutaneous rotator interval approach for simulated adhesiolysis: A proof-of-concept feasibility and anatomical safety study

    J Anesth Transl Med 2026-10-12 Rodríguez-Maruri G, Álvarez-Hornia E, Ciftci HB et al. PMID 42903887

  10. Future-proofing thalassaemia care: harnessing scalable therapies, artificial intelligence, and global collaboration

    Lancet Haematol 2026-10-06 Al-Samkari H, Aboobacker F, Andemariam B et al. PMID 42838072

  11. The expanding therapeutic landscape of β-thalassaemia

    Lancet Haematol 2026-10-06 Musallam KM, Sheth S, Locatelli F et al. PMID 42838069

  12. Potential contribution of the microbiota-gut-brain axis to doxorubicin-associated cognitive impairment: Mechanisms, evidence, and therapeutic opportunities

    Pharmacol Res 2026-09-15 Madkoor M, Ahmed R, Hany R et al. PMID 42744193

New drugs and therapies (papers)

Phase 1–3 and randomized trials of drugs, antibodies, vaccines and new therapies.

Showing the latest 12 of 16 matches

  1. Full enrollment results from cohort 1 of the phase III randomized THOR trial of erdafitinib versus chemotherapy in FGFR-altered advanced urothelial carcinoma

    ESMO Open 2026-09-30 Loriot Y, Matsubara N, Park SH et al. PMID 42815410

  2. Efficacy and safety of mitapivat in adults with transfusion-dependent α-thalassaemia or β-thalassaemia (ENERGIZE-T): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial

    Lancet 2026-09-12 Cappellini MD, Sheth S, Taher A et al. PMID 42721980

  3. SBUF-SMUF: On the path to the optimum hemofiltration technique in pediatric cardiopulmonary bypass: A randomized clinical trial

    J Extra Corpor Technol 2026-09-01 Shadmehr M, Ali B, Abdollahzadeh R et al. PMID 42743423

  4. Adapting mHealth Interventions to Improve Self-Management of HIV and Reduce Substance Use Among Emerging Adults in Zambia: Protocol for a Randomized Controlled Trial

    JMIR Res Protoc 2026-07-17 Wang B, MacDonell K, Zulu J et al. PMID 42470201

  5. L-citrulline treatment of nitric oxide deficiency in MELAS a phase I dose-finding and safety study

    Mol Genet Metab 2026-07-14 Almannai M, Duong J, El-Hattab AW et al. PMID 42520344

  6. Effects of online content-focused coaching on reducing the risk of professional burnout among elementary school teachers: The example of educational leadership in the United Arab Emirates

    J Gen Psychol 2026-07-01 Abdallah AK PMID 41231755

  7. Electromagnetic stimulation for overactive bladder in myelomeningocele children: randomized controlled trial

    Eur J Phys Rehabil Med 2026-06-01 Khalifa HA, Heneidy WE, Abdelrazek M et al. PMID 42394542

  8. Plant-dominant low-protein diet versus standard care in adults with chronic kidney disease stages 3-5: A randomized controlled trial protocol

    Nutr Res 2026-04-22 Kharma JA, Sultan R, Rizk R et al. PMID 42155424

  9. Clinical, radiographic and histomorphometric assessment of the effects of melatonin gel mixed with a xenograft in augmentation of the maxillary sinus: a randomized controlled clinical trial

    BMC Oral Health 2026-04-16 ElSholkamy M, Makawi DM, ElKhateeb SM et al. PMID 41987188

  10. Effectiveness of the mobile learning HiSense Taxi App for improving taxi drivers' services for individuals with disabilities: a randomized controlled trial

    Disabil Rehabil Assist Technol 2026-04-07 Buist-Brink PNP, Vacaru VSS, Sterkenburg PSP PMID 41945624

  11. Mechanistic insights into fecal microbiota transplantation for the treatment of ulcerative colitis: analysis of the STOP-Colitis trial

    J Crohns Colitis 2026-03-10 Quraishi MN, Moakes CA, Yalchin M et al. PMID 41587946

  12. Atrial Fibrillation Screening According to Genetic Risk: A Secondary Analysis of the Randomized LOOP Study

    J Am Coll Cardiol 2026-01-20 Vad OB, Diederichsen SZ, Xing LY et al. PMID 41159983

Drug trials started in the last year

Drug studies registered on ClinicalTrials.gov with a site in this country, newest first.

Showing the latest 12 of 17 matches

  1. A Phase 1, Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of ISM9528

    NCT07932041 Phase: Phase 1 Started: 2026-10-29 Sponsor: InSilico Medicine Hong Kong Limited Conditions: Healthy Subjects (HS) Drug / intervention: ISM9528 capsules

  2. A Study to Describe Multiple Sclerosis Patients Treated With Tolebrutinib as Per Label in a Real-world Setting

    NCT07898371 Started: 2026-10-01 Sponsor: Sanofi Conditions: Multiple Sclerosis Drug / intervention: Tolebrutinib

  3. Real-World Patient and Physician Experience With Semaglutide Across Six Emerging Markets

    NCT07850765 Started: 2026-08-28 Sponsor: Novo Nordisk A/S Conditions: Overweight, Obesity Drug / intervention: Semaglutide

  4. A Study to Investigate CV Outcomes With Elecoglipron Compared With Placebo in Adult Participants With HFpEF or HFmrEF

    NCT07761117 Phase: Phase 3 Started: 2026-08-24 Sponsor: AstraZeneca Conditions: Heart Failure With Preserved Ejection Fraction (HFpEF), Heart Failure With Mildly Reduced Ejection Fraction (HFmrEF) Drug / intervention: Elecoglipron, Placebo

  5. A Study to Investigate Outcomes With Elecoglipron Compared With Placebo in Adult Participants With Chronic Kidney Disease.

    NCT07753993 Phase: Phase 3 Started: 2026-08-21 Sponsor: AstraZeneca Conditions: Chronic Kidney Disease Drug / intervention: Elecoglipron, Placebo

  6. Safety and Tolerability of Difelikefalin in Adolescents on Haemodialysis With Moderate-to-Severe Pruritus

    NCT06593392 Phase: Phase 2 Started: 2026-08-04 Sponsor: Vifor Fresenius Medical Care Renal Pharma Conditions: Pruritus, Chronic Kidney Diseases Drug / intervention: Difelikefalin

  7. A Study of Orforglipron (LY3502970) in Participants With Type 2 Diabetes Who Observe Ramadan Fasting

    NCT07613307 Phase: Phase 3 Started: 2026-07-15 Sponsor: Eli Lilly and Company Conditions: Diabetes Mellitus, Type 2, Diabetes Melletus, Glucose Metabolism Disorders Drug / intervention: Orforglipron

  8. BEYOND Study: A Multicentre, Prospective, Observational Study of Real-world Treatment Patterns and Outcomes of Trastuzumab Deruxtecan in Patients With HR Positive, HER2-low or Ultra-low Metastatic Breast Cancer Previously Treated With Endocrine Therapy

    NCT07597993 Started: 2026-07-12 Sponsor: AstraZeneca Conditions: Breast Cancer Drug / intervention: TDxd

  9. Efficacy of Recombinant Human G-CSF in Women With Unexplained Recurrent Miscarriage

    NCT07724405 Phase: Phase 2 Started: 2026-07-10 Sponsor: Fakih IVF Fertility Center Conditions: Recurrent Pregnancy Loss, Recurrent Miscarriages Drug / intervention: Placebo control, Recombinant G-CSF

  10. A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East

    NCT07215975 Started: 2026-06-26 Sponsor: Bristol-Myers Squibb Conditions: β-thalassemia Drug / intervention: Luspatercept

  11. A Phase IIIb Study to Evaluate Camizestrant Plus Ribociclib in ER-positive, HER2-negative Advanced Breast Cancer

    NCT07647328 Phase: Phase 3 Started: 2026-06-15 Sponsor: AstraZeneca Conditions: ER-Positive HER2-Negative Breast Cancer Drug / intervention: Camizestrant, Ribociclib

  12. Study to Evaluate the Effect of HT-4253 for the Prevention of Alzheimer's Disease in APOE4 Carriers

    NCT07399171 Phase: Phase 2 Started: 2026-05-12 Sponsor: Halia Therapeutics, Inc. Conditions: Alzheimers Disease Drug / intervention: HT-4253, Placebo

Diseases and population studies

Nationwide cohorts, registries and population-based studies on incidence and prevalence.

Showing the latest 12 of 675 matches

  1. Post-Bariatric Hypoglycaemia in a Middle Eastern Tertiary Bariatric Population: A Case-Control Analysis of Prevalence, Associated Factors, and Metabolic Trajectories

    Obes Surg 2026-11-16 Abdelgadir E, Rashid F, Bashier A et al. PMID 43035620

  2. Dynamics of a vector-host epidemic model with generalized nonlinear incidence functions and distinct dispersal kernels

    Math Biosci 2026-11-12 Dey S, Kumar Kar T, Tridane A PMID 43020195

  3. Association between psoriatic disease and dyslipidaemia: a chart-based observational study in the United Arab Emirates

    BMJ Open 2026-11-11 Almarzooqi K, Almarzooqi N, Alghefari A et al. PMID 43015025

  4. The synthetic biology frontier: engineered oncolytic viruses and viral vectors for next-generation cancer therapy and gene delivery

    RSC Adv 2026-11-09 Alsharedeh RH, Aljabali AAA, Obeid MA et al. PMID 43005928

  5. Development and validation of the Arabic international index of erectile Function-5 (IIEF-5): a population-based assessment of erectile dysfunction severity and its associated factors among Arabic-speaking older men

    J Sex Med 2026-11-06 Jairoun AA, Shahwan M, El-Dahiyat F et al. PMID 43002586

  6. Guillain-Barré Syndrome Following Bariatric Surgery: A Systematic Literature Review

    Obes Surg 2026-11-06 Aljaberi A, Nair SC, Kamrul-Hasan ABM et al. PMID 42993445

  7. Industrialization restructures the domestic dog gut microbiome while preserving host specificity

    mSystems 2026-11-06 Gautam A, Bhandari D, Gurung K et al. PMID 42992834

  8. Pharmacogenomics positively impacts polypharmacy-related toxicity and clinical outcomes in psychiatric patients

    Pharmacol Res 2026-11-05 Pandi MT, Koufaki MI, Skokou M et al. PMID 42988188

  9. Global, regional, and national burden of gallbladder and biliary diseases in 204 countries and territories, 1990-2023: a systematic analysis for the Global Burden of Disease Study 2023

    Lancet Gastroenterol Hepatol 2026-11-04 GBD 2023 Gallbladder and Biliary Disease Collaborators PMID 42982068

  10. Prior Coronary Artery Bypass Grafting and Its Impact on Lesion Complexity, Procedural Characteristics, and Outcomes in Chronic Total Occlusion Percutaneous Coronary Intervention: A Systematic Review and Meta-Analysis

    Cardiol Rev 2026-11-03 Azam H, Alam B, Javaid SS et al. PMID 42975985

  11. Dupilumab in Pediatric Eosinophilic Esophagitis

    Pediatrics 2026-11-03 Russo G, Alsarhan A, Slae M et al. PMID 42971260

  12. Prevalence and Association of Undiagnosed Obstructive Sleep Apnea with Perioperative Neurocognitive Disorders, and Quality of Life After Brain Surgery

    Neurol India 2026-11-01 Akula S, Kandiraju SR, Rao S et al. PMID 43023793

Source: PubMed · ClinicalTrials.gov